Antidepresan: Perbedaan antara revisi

'''Antidepresan''' adalah sebuah [[obat]] yang digunakan untuk mengobati [[gangguan depresi mayor]], beberapa [[gangguan kecemasan]], beberapa kondisi [[nyeri kronis]], dan untuk membantu mengelola beberapa [[kecanduan]].<ref name="Jennings2018">{{cite book|title=Clinical psychopharmacology for neurologists: a practical guide|last1=Jennings|first1=Leigh|date=2018|publisher=Springer|isbn=978-3-319-74602-9|editor1-last=Grossberg|editor1-first=George T.|pages=45–71|chapter=Chapter 4: Antidepressants|doi=10.1007/978-3-319-74604-3_4|editor2-last=Kinsella|editor2-first=Laurence J.}}</ref> [[Efek samping]] umum dari antidepresan termasuk [[Xerostomia|mulut kering]], [[penambahan berat badan]], [[pusing]], [[sakit kepala]], dan [[disfungsi seksual]].<ref>{{cite journal | vauthors = Healy D, Noury LJ, Manginb D | title = Enduring sexual dysfunction after treatment with antidepressants, 5α-reductase inhibitors and isotretinoin: 300 cases | journal = International Journal of Risk & Safety in Medicine | volume = 29 | issue = 3 | pages = 125–134 | date = May 2018 | pmid = 29733030 | pmc = 6004900 | doi = 10.3233/JRS-180744 }}</ref><ref name="Bahrick">{{cite journal |doi=10.2174/1874350100801010042 |title=Persistence of Sexual Dysfunction Side Effects after Discontinuation of Antidepressant Medications: Emerging Evidence |journal=The Open Psychology Journal |volume=1 |pages=42–50 |year=2008 |last1=Bahrick |first1=Audrey S. | name-list-format = vanc }}</ref><ref>{{cite journal | vauthors = Taylor MJ, Rudkin L, Bullemor-Day P, Lubin J, Chukwujekwu C, Hawton K | title = Strategies for managing sexual dysfunction induced by antidepressant medication | journal = The Cochrane Database of Systematic Reviews | volume = 5 | issue = 5 | pages = CD003382 | date = May 2013 | pmid = 23728643 | doi = 10.1002/14651858.CD003382.pub3 | url = https://kclpure.kcl.ac.uk/portal/en/publications/strategies-for-managing-sexual-dysfunction-induced-by-antidepressant-medication(5f0f0033-e139-42cc-9590-d3b5cad1bb25).html }}</ref><ref>{{cite journal | vauthors = Kennedy SH, Rizvi S | title = Sexual dysfunction, depression, and the impact of antidepressants | journal = Journal of Clinical Psychopharmacology | volume = 29 | issue = 2 | pages = 157–64 | date = April 2009 | pmid = 19512977 | doi = 10.1097/jcp.0b013e31819c76e9 }}</ref><ref>[https://www.ema.europa.eu/en/documents/other/new-product-information-wording-extracts-prac-recommendations-signals-adopted-13-16-may-2019-prac_en.pdf Serotonin and noradrenaline reuptake inhibitors (SNRI); selective serotonin reuptake inhibitors (SSRI) – Persistent sexual dysfunction after drug withdrawal ](EPITT no 19277), 11 June 20191, EMA/PRAC/265221/2019, Pharmacovigilance Risk Assessment Committee (PRAC)</ref>